Trinity Biotech ROA 2006-2018 | TRIB

Current and historical return on assets (ROA) values for Trinity Biotech (TRIB) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Trinity Biotech ROA for the three months ending September 30, 2018 was 1.30%.
Trinity Biotech ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.04B $0.18B -21.44%
2018-06-30 $-0.04B $0.19B -20.31%
2018-03-31 $-0.04B $0.20B -19.13%
2017-12-31 $-0.04B $0.19B -17.67%
2017-09-30 $-0.10B $0.25B -40.20%
2017-06-30 $-0.10B $0.25B -36.36%
2017-03-31 $-0.10B $0.25B -32.65%
2016-12-31 $-0.10B $0.25B -30.42%
2016-09-30 $0.00B $0.36B 0.83%
2016-06-30 $0.02B $0.36B 4.45%
2016-03-31 $0.02B $0.36B 4.73%
2015-12-31 $0.02B $0.36B 6.64%
2015-09-30 $0.02B $0.36B 7.63%
2015-06-30 $0.02B $0.36B 5.52%
2015-03-31 $0.02B $0.25B 6.63%
2014-12-31 $0.02B $0.24B 6.76%
2014-09-30 $0.02B $0.24B 7.31%
2014-06-30 $0.01B $0.24B 4.37%
2014-03-31 $0.01B $0.23B 4.54%
2013-12-31 $0.01B $0.23B 4.68%
2013-09-30 $0.01B $0.22B 4.36%
2013-06-30 $0.02B $0.20B 8.07%
2013-03-31 $0.02B $0.20B 8.27%
2012-12-31 $0.02B $0.20B 8.50%
2012-09-30 $0.02B $0.19B 8.80%
2012-06-30 $0.02B $0.18B 9.05%
2012-03-31 $0.02B $0.18B 9.26%
2011-12-31 $0.02B $0.17B 9.48%
2011-09-30 $0.02B $0.17B 9.62%
2011-06-30 $0.02B $0.17B 9.19%
2011-03-31 $0.06B $0.17B 38.87%
2010-12-31 $0.06B $0.16B 40.40%
2010-09-30 $0.06B $0.16B 41.74%
2010-06-30 $0.06B $0.15B 43.88%
2010-03-31 $0.01B $0.13B 9.14%
2009-12-31 $0.01B $0.13B 9.27%
2009-09-30 $-0.07B $0.13B -56.59%
2009-06-30 $-0.08B $0.13B -49.83%
2009-03-31 $-0.08B $0.13B -44.19%
2008-12-31 $-0.08B $0.13B -40.21%
2008-09-30 $-0.04B $0.22B -17.17%
2008-06-30 $-0.04B $0.22B -17.04%
2008-03-31 $-0.04B $0.21B -16.03%
2007-12-31 $-0.04B $0.22B -19.72%
2007-09-30 $0.01B $0.25B 4.31%
2007-06-30 $0.01B $0.25B 5.92%
2007-03-31 $0.01B $0.00B 4.85%
2006-12-31 $0.00B $0.25B 3.23%
2006-09-30 $0.00B $0.25B 2.78%
2006-06-30 $0.00B $0.00B 2.20%
2006-03-31 $0.01B $0.00B 3.82%
2005-12-31 $0.01B $0.19B 2.94%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.066B $0.099B
Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.543B 19.40
Abbott Laboratories (ABT) United States $126.526B 25.64
Stryker (SYK) United States $64.420B 24.28
Boston Scientific (BSX) United States $51.491B 26.02
Baxter (BAX) United States $35.393B 22.86
Zimmer Biomet Holdings (ZBH) United States $23.875B 15.48
Smith & Nephew SNATS (SNN) United Kingdom $16.038B 0.00
ResMed (RMD) United States $14.846B 28.31
Perrigo (PRGO) Ireland $8.596B 13.05
Bio-Rad Laboratories (BIO) United States $8.274B 52.91
Canopy Growth (CGC) Canada $8.174B 0.00
Hill-Rom Holdings (HRC) United States $6.270B 19.88
Aurora Cannabis (ACB) Canada $6.172B 33.68
Haemonetics (HAE) United States $5.727B 50.36
ICU Medical (ICUI) United States $4.968B 27.68
Insulet (PODD) United States $4.838B 0.00
Agios Pharmaceuticals (AGIO) United States $4.052B 0.00
Hutchison China MediTech (HCM) China $4.010B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.990B 0.00
Neogen (NEOG) United States $3.294B 49.88
NuVasive (NUVA) United States $3.166B 29.46
National Vision Holdings (EYE) United States $3.024B 58.49
Quidel (QDEL) United States $2.507B 32.68
Aphria (APHA) $2.433B 0.00
NxStage Medical (NXTM) United States $1.933B 0.00
Phibro Animal Health (PAHC) United States $1.409B 19.95
AtriCure (ATRC) United States $1.241B 0.00
Cardiovascular Systems (CSII) United States $1.058B 1524.50
VAREX IMAGING (VREX) United States $0.999B 20.07
Meridian Bioscience (VIVO) United States $0.823B 26.23
Surmodics (SRDX) United States $0.794B 121.41
OraSure Technologies (OSUR) United States $0.772B 43.48
Eagle Pharmaceuticals (EGRX) United States $0.756B 24.24
MacroGenics (MGNX) United States $0.740B 0.00
Cerus (CERS) United States $0.716B 0.00
PetIQ (PETQ) United States $0.705B 20.03
Lantheus Holdings (LNTH) United States $0.625B 19.34
Omeros (OMER) United States $0.619B 0.00
LeMaitre Vascular (LMAT) United States $0.540B 26.52
Owens & Minor (OMI) United States $0.535B 6.05
Insys Therapeutics (INSY) United States $0.527B 0.00
NanoString Technologies (NSTG) United States $0.521B 0.00
TG Therapeutics (TGTX) United States $0.444B 0.00
Evolus (EOLS) United States $0.403B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.332B 21.45
Cytosorbents (CTSO) United States $0.313B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.264B 0.00
Surface Oncology (SURF) United States $0.225B 0.00
Rockwell Medical (RMTI) United States $0.214B 0.00
BioLife Solutions (BLFS) United States $0.204B 275.00
Chimerix (CMRX) United States $0.172B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.146B 0.00
Fonar (FONR) United States $0.141B 7.06
Imprimis Pharmaceuticals (IMMY) United States $0.123B 0.00
Chembio Diagnostics (CEMI) United States $0.106B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Capricor Therapeutics (CAPR) United States $0.029B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Senestech (SNES) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00